GeorgeEarlGeorgesMD

Oncology • Chicago, IL

Associate Member Fred Hutchinson Cancer Research CenterAssociate Professor University of Washington

Join to view full profile

Dr. Georges is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Georges' full profile

Already have an account?

Office
303 E Superior St
Ste 5-105
Chicago, IL 60611
Phone+1 312-503-1761

Fax+1 312-908-5717

Education & Training

University of WashingtonFellowship, Hematology and Medical Oncology, 1997
University of Texas Southwestern Medical CenterResidency, Internal Medicine, 1990 - 1993
University of Texas Southwestern Medical CenterInternship, Internal Medicine, 1990 - 1991
University of California San Francisco School of MedicineClass of 1990

Certifications & Licensure

IL State Medical License 2023 - 2026
WA State Medical License 1994 - 2024
TX State Medical License 1991 - 1995
American Board of Internal Medicine Medical Oncology

Clinical Trials

Combination Chemotherapy and Total-Body Irradiation Followed by Peripheral Stem Cell or Bone Marrow Transplantation in Treating Patients With Acute Lymphoblastic Leukemia Start of enrollment: 2001 Jul 01
Completed
Phase 1, Phase 2
Reduced Intensity Donor Stem Cell Transplant in Treating Patients With High Risk Acute Lymphocytic Leukemia in Complete Remission Start of enrollment: 2001 Sep 01
Completed
Phase 2
Fludarabine Phosphate and Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia or Chronic Myelogenous Leukemia That Has Responded to Treatment With Imatinib Mesylate, Dasatinib, or Nilotinib Start of enrollment: 2001 Jul 13
Completed
Phase 2
High-Dose Immunosuppression and Autologous Transplantation for Multiple Sclerosis (HALT MS) Study Start of enrollment: 2006 Jul 01
Completed
Phase 2
Allogeneic Hematopoietic Cell Transplantation for Severe Systemic Sclerosis Start of enrollment: 2006 Sep 01
Completed
Phase 1, Phase 2
Autologous Stem Cell Transplant for Neurologic Autoimmune Diseases Start of enrollment: 2008 Jun 01
Active, not recruiting
Phase 2
Low-Dose Conditioning Followed by Donor Stem Cell Transplant in Treating Patients With Severe Systemic Sclerosis
Withdrawn
Phase 2
Scleroderma Treatment With Autologous Transplant (STAT) Study Start of enrollment: 2011 Sep 15
Active, not recruiting
Phase 2
Gene Expression That Predicts Radiation Exposure in Humans Start of enrollment: 2017 Apr 06
Completed
Best Available Therapy Versus Autologous Hematopoetic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS) Start of enrollment: 2019 Dec 19
Recruiting
Phase 3
Join now to see all

Publications & Presentations

PubMed

328 citations
Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma.
Keith M. Sullivan, Ellen Goldmuntz, Lynette Keyes-Elstein, Peter A. McSweeney, Ashley Pinckney
The New England Journal of Medicine. 2018-01-03
199 citations
Allogeneic hematopoietic stem cell transplantation for myelofibrosis
H. Joachim Deeg, T. Gooley, Mary E.D. Flowers, George E. Sale, John T. Slattery
Blood. 2003-12-01
167 citations
Long-term Outcomes After Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis.
Paolo A. Muraro, Marcelo C. Pasquini, Harold L. Atkins, James Bowen, Dominique Farge
JAMA Neurology. 2017-04-01

Grant Support

Radiation Dose-Dependent InterventionsNational Institute Of Allergy And Infectious Diseases2005–2010
Transplantation Of Cord BloodNational Institute Of Allergy And Infectious Diseases2005–2009
Core--Pilot Research ProjectsNational Institute Of Allergy And Infectious Diseases2005–2009
Immunosupression-Resistant Gene Modified Donor T CellsNational Cancer Institute2005–2009
Improving Platelet Recovery After RadiationNational Institute Of Allergy And Infectious Diseases2008
Improving Gastrointestinal Recovery After RadiationNational Institute Of Allergy And Infectious Diseases2007
Cytokines For Immune Protection From Acute IrradiationNational Institute Of Allergy And Infectious Diseases2005
AdministrationNational Institute Of Allergy And Infectious Diseases2005
Gene Modified Donor T Cell Infusion Into Mixed ChimerasNational Institute Of Diabetes And Digestive And Kidney Diseases2002–2003
Gene Modified T-Cells For Engraftment And GVHD ControlNational Institute Of Diabetes And Digestive And Kidney Diseases2000–2003
Gene Modified T Cells For Engraftment And GVHD ControlNational Institute Of Diabetes And Digestive And Kidney Diseases1999
Gene Modified T Cells In A Model To Control GVHDNational Institute Of Diabetes And Digestive And Kidney Diseases1997–1998